Stay updated on Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.

Latest updates to the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedUpdated page revision from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check21 days agoChange DetectedRevision: v3.4.3 added and v3.4.2 removed. No other visible content changes are shown.SummaryDifference0.1%

- Check28 days agoNo Change Detected
- Check50 days agoChange DetectedRevision: v3.4.2 added and older maintenance notices (including the v3.4.1 revision and a funding-status notice) removed; no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check57 days agoChange DetectedAdded a site-wide notice about a lapse in government funding informing users that updates may not be up to date and providing status of the NIH Clinical Center, and updated the page revision from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check64 days agoChange DetectedThe glossary feature is now visible, and the page includes new metadata entries: Last Update Submitted that Met QC Criteria, No FEAR Act Data, and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check78 days agoChange DetectedRevision updated from v3.3.3 to v3.3.4. No visible changes to the study details content or layout.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab in Kaposi's Sarcoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Kaposi's Sarcoma Clinical Trial page.